ClinicalTrials.gov
public full text
Public Domain
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies#1095388
- CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy#140982
- CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies#148759
- Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)#1031138
- Association of Polygenic Risk Scores of the Different B Cell Malignancies with the Risk of B Cell Acute Lymphoblastic Leukemia: Case-Control Study#824195
Record · ID 467579
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive